← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2009Last known activity
Oct 18, 2025
Timeline
1920s
- Jan 1, 1926
Yuhan Pharmaceutical Company— Founded
Drugs by trial phase (76 distinct, 108 trials)
Phase 4 (18 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (28 own, 0 via acquisition)
Phase 1 (18 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Acute Disease
- Alzheimer Disease
- Angina, Stable
- Asthma
- Atherosclerosis
- Bronchitis
- Bronchitis, Chronic
- Carcinoma, Non-Small-Cell Lung
- Cardiovascular Diseases
- Chronic Periodontitis
- Colorectal Neoplasms
- Constipation
- Coronary Artery Disease
- Dementia
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Dyslipidemias
- Dyspepsia
- Erectile Dysfunction
- Esophagitis
- Esophagitis, Peptic
- Gastroesophageal Reflux
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertension
- Inflammation
- Intervertebral Disc Degeneration
- Kidney Diseases
- Lung Neoplasms
- Metabolic Syndrome
- Neuralgia
- Osteoarthritis
- Osteoarthritis, Knee
- Otitis
- Otitis Media
- Periodontal Diseases
- Periodontitis
- Peripheral Arterial Disease
- Peripheral Nervous System Diseases
- Plaque, Atherosclerotic
- Premature Birth
- Premature Ejaculation
- Proteinuria
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Respiration Disorders
- Respiratory Tract Diseases
- Rheumatic Fever
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Seasonal
- Spinal Diseases
- Syndrome
- Thrombocythemia, Essential
- Thrombocytosis
- Thrombophilia
Recent trials (50)
- NCT04829422Lead sponsorN/A—
- NCT07265167Lead sponsorPhase 1Oct 18, 2025
- NCT07111468Lead sponsorPhase 3Oct 17, 2025
- NCT06920719Lead sponsorPhase 1Jun 29, 2025
- NCT06975410Lead sponsorPhase 1/Phase 2Jun 12, 2025
- NCT06975410OfficialPhase 1/Phase 2Jun 12, 2025
- NCT06767345CollaboratorPhase 4May 12, 2025
- NCT06926387Lead sponsorPhase 1Apr 17, 2025
- NCT06775522Lead sponsorPhase 1Jan 11, 2025
- NCT06625957Lead sponsorPhase 3Dec 31, 2024
- NCT06625931Lead sponsorPhase 3Dec 27, 2024
- NCT06616766OfficialPhase 1/Phase 2Oct 31, 2024
- NCT06616766Lead sponsorPhase 1/Phase 2Oct 31, 2024
- NCT06613139Lead sponsorPhase 1Oct 6, 2024
- NCT06623526Lead sponsorPhase 1Oct 4, 2024
Details
- Founded
- Seoul, KR Jan 1, 1926
- Last known activity
- Oct 18, 2025